These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 8894306

  • 1. N alpha-acetylcarnosine is a prodrug of L-carnosine in ophthalmic application as antioxidant.
    Babizhayev MA, Yermakova VN, Sakina NL, Evstigneeva RP, Rozhkova EA, Zheltukhina GA.
    Clin Chim Acta; 1996 Oct 15; 254(1):1-21. PubMed ID: 8894306
    [Abstract] [Full Text] [Related]

  • 2. The natural histidine-containing dipeptide Nalpha-acetylcarnosine as an antioxidant for ophthalmic use.
    Babizhayev MA, Yermakova VN, Semiletov YA, Deyev AI.
    Biochemistry (Mosc); 2000 May 15; 65(5):588-98. PubMed ID: 10851037
    [Abstract] [Full Text] [Related]

  • 3. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention.
    Babizhayev MA.
    Drugs R D; 2005 May 15; 6(6):345-69. PubMed ID: 16274259
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of intraocular absorption and drug metabolism of N-acetylcarnosine lubricant eye drops: drug interaction with sight threatening lipid peroxides in the treatment for age-related eye diseases.
    Babizhayev MA.
    Drug Metabol Drug Interact; 2009 May 15; 24(2-4):275-323. PubMed ID: 20408504
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bioactivation antioxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye-drop formulation: powerful eye health application technique and therapeutic platform.
    Babizhayev MA.
    Drug Test Anal; 2012 Jun 15; 4(6):468-85. PubMed ID: 21416634
    [Abstract] [Full Text] [Related]

  • 8. N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patients.
    Babizhayev MA, Micans P, Guiotto A, Kasus-Jacobi A.
    Am J Ther; 2009 Jun 15; 16(6):517-33. PubMed ID: 19487926
    [Abstract] [Full Text] [Related]

  • 9. Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops. Kinetic, Pharmacological and Activity-Dependent Separation of Therapeutic Targeting: Transcorneal Penetration and Delivery of L-Carnosine in the Aqueous Humor and Hormone-Like Hypothalamic Antiaging Effects of the Instilled Ophthalmic Drug Through a Safe Eye Medication Technique.
    Babizhayev MA, Yegorov YE.
    Recent Pat Drug Deliv Formul; 2016 Jun 15; 10(2):82-129. PubMed ID: 26084629
    [Abstract] [Full Text] [Related]

  • 10. N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population.
    Babizhayev MA, Burke L, Micans P, Richer SP.
    Clin Interv Aging; 2009 Jun 15; 4():31-50. PubMed ID: 19503764
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mitochondria induce oxidative stress, generation of reactive oxygen species and redox state unbalance of the eye lens leading to human cataract formation: disruption of redox lens organization by phospholipid hydroperoxides as a common basis for cataract disease.
    Babizhayev MA.
    Cell Biochem Funct; 2011 Apr 15; 29(3):183-206. PubMed ID: 21381059
    [Abstract] [Full Text] [Related]

  • 14. Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes.
    Babizhayev MA, Deyev AI, Yermakova VN, Brikman IV, Bours J.
    Drugs R D; 2004 Apr 15; 5(3):125-39. PubMed ID: 15139774
    [Abstract] [Full Text] [Related]

  • 15. Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine.
    Babizhayev MA.
    Fundam Clin Pharmacol; 2012 Feb 15; 26(1):86-117. PubMed ID: 21883446
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Novel intraocular and systemic absorption drug delivery and efficacy of N-acetylcarnosine lubricant eye drops or carcinine biologics in pharmaceutical usage and therapeutic vision care.
    Babizhayev MA, Khoroshilova-Maslova IP, Kasus-Jacobi A.
    Fundam Clin Pharmacol; 2012 Oct 15; 26(5):644-78. PubMed ID: 21793899
    [Abstract] [Full Text] [Related]

  • 18. Ocular pharmacokinetics of carnosine 5% eye drops following topical application in rabbit.
    Tianyang Z, Ling Z, Liya W, Junjie Z.
    J Ocul Pharmacol Ther; 2011 Feb 15; 27(1):93-7. PubMed ID: 20085487
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Generation of reactive oxygen species in the anterior eye segment. Synergistic codrugs of N-acetylcarnosine lubricant eye drops and mitochondria-targeted antioxidant act as a powerful therapeutic platform for the treatment of cataracts and primary open-angle glaucoma.
    Babizhayev MA.
    BBA Clin; 2016 Dec 15; 6():49-68. PubMed ID: 27413694
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.